FDA studying if gel for diabetic ulcers causes cancer
Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.
Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early company.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Recent Videos
